SotalolTorsades de Pointes (TdP) secondary to prolonged QT-interval: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1819卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82801-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[21] AmiodaroneTorsades de pointes secondary to QT prolongation: case report
Reactions Weekly, 2020, 1813 (1) : 21 - 21
[22] MethadoneTorsades de pointes secondary to QT prolongation: case report
Reactions Weekly, 2020, 1806 (1) : 181 - 181
[23] LevetiracetamFirst report of QT interval prolongation and Torsades de pointes: case report
Reactions Weekly, 2015, 1561 (1) : 111 - 111
[24] EfavirenzFirst report of QT interval prolongation and torsade de pointes: case report
Reactions Weekly, 2002, 912 (1) : 7 - 8
[25] MethadoneProlonged corrected QT interval and Torsade de Pointes: case report
Reactions Weekly, 2021, 1868 (1) : 247 - 247
[26] MethadoneTorsades de pointes due to QT interval prolongation: case report
Reactions Weekly, 2013, 1463 (1) : 24 - 24
[27] Evaluating the risk of Torsades de pointes with fluoroquinolones: an analysis of QT-interval and QT-dispersion.
Peeters, MJ
Tsikouris, JP
Cox, CD
Meyerrose, GE
Seifert, CF
PHARMACOTHERAPY, 2004, 24 (10): : 1424 - 1424
[28] HydroxyzineSyncope, QT interval prolongation and torsade de pointes: case report
Reactions Weekly, 2009, 1245 (1) : 20 - 21
[29] Prolonged QT-interval in cirrhosis: is it reversible?
Moller, Soren
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 329 : 113 - 114
[30] Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes
Antzelevitch, Charles
EUROPACE, 2007, 9 : 4 - 15

← 1 2 3 4 5 →